<DOC>
	<DOCNO>NCT00111852</DOCNO>
	<brief_summary>The purpose study evaluate desmoteplase ( manufactured protein derive saliva vampire bat ) dissolve clot block flow blood one ( ) blood vessel supply brain , thereby reopen block blood vessel allow blood flow individual suffer ischemic stroke .</brief_summary>
	<brief_title>Study Desmoteplase ( International Nonproprietary Name INN ) Acute Ischemic Stroke ( DIAS-2 )</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Salivary plasminogen activator alpha 1 , Desmodus rotundus</mesh_term>
	<criteria>Eligible study treatment within 39 hour onset stroke symptom . Score 424 NIHSS clinical sign hemispheric infarction ( i.e . hemiparesis ) suggestive ischemic stroke . Inclusion Criteria diagnostic imaging screening : Distinct penumbra ( least 20 % ) , measure MRI ( PWI/DWI ) perfusion CT , relate middle cerebral artery ( MCA ) , anterior cerebral artery ( ACA ) , posterior cerebral artery ( PCA ) territory hemispheric distribution . History clinical presentation intracranial hemorrhage ( ICH ) , subarachnoid hemorrhage , arteriovenous malformation , aneurysm , cerebral neoplasm . Rapidly improve neurological symptom . Prestroke MRS score &gt; 1 ( include previous disability ) . Suspected acute vertebral basilar artery occlusion . Current use anticoagulant prolong prothrombin time . Uncontrolled hypertension . Baseline hematocrit &lt; 0.25 . Baseline platelet count &lt; 100,000/mm3 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Desmoteplase</keyword>
	<keyword>Acute Ischemic Stroke</keyword>
	<keyword>Stroke , Acute</keyword>
</DOC>